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Abstract: (1) Background: Mastectomy is the surgical treatment of choice in 20–30% of women with
breast cancer. In addition, more women are undergoing risk-reducing mastectomies. It is necessary to
study these women’s quality of life and satisfaction after surgery, as studies report high percentages
of dissatisfaction with the results. The publication of the BREAST-Q© questionnaire in 2009 provided
a valuable tool to measure these results. (2) Methods: Descriptive, cross-sectional study of 70 patients
who underwent mastectomy and breast reconstruction, both therapeutic and prophylactic, in the
last 10 years to whom the BREAST-Q© 2.0-Reconstruction Module questionnaire was provided for
completion. (3) Results: The sexual satisfaction scale was the lowest score of the entire questionnaire
(51.84 ± 21.13), while the highest score was obtained on the satisfaction with the surgeon scale
(91.86 ± 18.11). The satisfaction with care scales showed the importance of the evaluation of these
items for future studies. More than half of the patients of the study (51.5%) underwent at least
one reoperation after the first surgery, with an average of one (1.15) intervention per patient and
a maximum of five. (4) Conclusions: Mastectomy and breast reconstruction have a high negative
impact on the sexual well-being of patients. The high percentage of reoperations is a factor to consider
because of its possible influence on these patients’ quality of life and satisfaction.
Keywords: breast cancer; breast cancer risk-reducing surgery; mastectomy; breast reconstruction;
quality of life; BREAST-Q
1. Introduction
Breast cancer is the most frequent malignant neoplasm in women. In 2020, there
were 2.3 million women diagnosed with breast cancer and 685,000 deaths globally. As
of the end of 2020, there were 7.8 million women alive who were diagnosed with breast
cancer in the past 5 years, making it the world’s most prevalent cancer. There are more lost
disability-adjusted life years (DALYs) by women to breast cancer globally than any other
type of cancer [1]. In the U.S., in 2021, an estimated 281,550 new cases of invasive breast
cancer are expected to be diagnosed in women in the U.S., along with 49,290 new cases of
non-invasive (in situ) breast cancer.
About 43,600 women in the U.S. are expected to die in 2021 from breast cancer. Death
rates have been steady in women under 50 since 2007, but have continued to drop in
women over 50. The overall death rate from breast cancer decreased by 1% per year from
2013 to 2018. These decreases are thought to be the result of treatment advances and earlier
detection through screening [2].
Recently Miller et al. analyzed population-based cancer incidence and mortality for
AYAs in the U.S. by age group (ages 15–19, 20–29, and 30–39 years), sex, and race/ethnicity.
In 2020, it was estimated approximately 89,500 new cancer cases and 9270 cancer deaths in
AYAs [3].
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In Spain it represents 36% of tumors in women with almost 33,000 new cases per
year. It is the leading cause of death from cancer in Spanish women, although, since the
1980s, there has been a downward trend in mortality. This is due to the combined effect of
screening programs, improved treatments, and multimodal therapy [4].
Despite the significant advances in tumor biology in recent years, surgery remains an
essential part of the primary treatment of breast cancer, although this has also evolved over
the years. Nowadays, it is possible to diagnose the tumor in its early stages, which allows
conservative surgery to be performed, thus minimizing the esthetic impact, as long as the
oncologic conditions allow it. However, conservative techniques are not always possible,
so mastectomy remains a frequent procedure, and approximately 20–30% of women with
breast cancer undergo it [5].
On the other hand, recent discoveries in the genetic basis of breast cancer have led to
increased interest in risk-reducing mastectomy as a method of breast cancer prevention [6,7].
Over the years, surgical strategies have changed. Although the primary objective
of treatment continues to be disease control, improved cosmetic results have become
more critical to reduce patients’ physical and psychological trauma. Thus, according to the
Halsted technique, mastectomy was replaced by modified radical mastectomy; the objective
has been to produce the aggression as atraumatic as possible. To this end, skin-sparing
mastectomy, where most of the skin envelope is preserved, and skin- and nipple-sparing
mastectomy, where, in addition, the nipple-areola complex can be preserved, have emerged
allowing better esthetic results after post-mastectomy reconstruction [8].
In addition, the increased survival of breast cancer patients has led to greater attention
to their quality of life. It is why breast reconstruction is now a necessary part of the overall
treatment. It has been shown not to influence patient survival [9] and helps restore body
image and relieve the stress associated with mastectomy [10].
Post-mastectomy reconstruction can be performed immediately or deferred. There
are various procedures for performing it (tissue expansion-prosthesis; autologous tissue),
the choice of which will depend on the patient’s characteristics, thus allowing the most
personalized treatment possible to be obtained [11].
Nevertheless, choosing the type of breast reconstruction is a difficult decision and
optimizing the results of breast cancer surgery remains a challenge. Approximately 40% of
women who undergo surgery reported dissatisfaction with their surgery’s decision and
esthetic results [12,13]. Some authors such as Shechter et al. reported that patients in the
breast reconstruction group had higher scores for esthetic outcome and a higher degree
of patient satisfaction from the surgical outcome compared to the patients in the breast
conservating treatment-alone group [14].
Lei et al. in a multi-center study identified factors of higher patient satisfaction, such
as NAC preservation and absence of radiotherapy, in order to help breast surgeons make
better decisions about individualized reconstruction plan [15].
Schmidt et al. reported that patients who found their breast to be highly important
were more likely to decide for a reconstruction. For these authors patients reporting a high
significance of their breast showed the greatest decrease in satisfaction with their breast
after reconstruction [16].
Therefore, the objective of this surgery, beyond the final esthetic result, must consider
how it will affect the patient’s quality of life and satisfaction. Thus, these variables have
become a fundamental part of evaluating the success of breast surgery [17].
In order to measure these variables of effect, we have questionnaires based on the
results reported by the patients themselves (“Patient-reported outcomes-PROs”). These
instruments quantify aspects related to health-related quality of life (HRQOL), such as, for
example, satisfaction; obtaining the information directly from the patient themself without
any interpretation by third parties; and, in addition, they include broader concepts such as
satisfaction with the care received [18].
Multiple instruments have been used to measure PROs in breast surgery patients.
However, until just over a decade ago, few of these questionnaires had sufficient evidence
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to be used specifically in these patients, as they had limitations in certain areas, such as
those related to esthetics and body perception [19].
In 2009, the BREAST-Q questionnaire was developed to meet this need, a validated
PRO instrument specific to breast surgery. Since its release, it has substantially improved
our ability to study the results of this procedure from the patient’s point of view and patient
satisfaction [20].
Drs. Pusic, Klassen, and Cano developed the BREAST-Q© questionnaire, owned by
Memorial Sloan-Kettering Center and Columbia University (U.S.). It has been available
for use in Spain since 2016 after linguistic validation, and in 2017 they launched version
2.0, which was tested on a much larger group of patients. It consists of six modules; two
modules related to esthetic purposes (breast augmentation and reduction) and the breast
cancer module, which encompasses the mastectomy, breast reconstruction, reconstruction
expectations, and breast-conserving surgery modules. All modules are based on a con-
ceptual structure with six domains that are grouped into two: the first domain related
to the quality of life that included: physical well-being, psychological well-being, and
sexual well-being. Moreover, the second domain is related to patient satisfaction (the
breasts, the results, and the medical care received). Each module contains preoperative and
postoperative scales, which can be used independently or together to measure changes [21].
Since the appearance of the BREAST-Q© questionnaire, many studies have used it
to evaluate breast surgery patients. However, these studies have identified limitations,
such as short follow-up periods or small sample sizes [13,22]. In contrast, other studies,
although extensive, are only limited to therapeutic reconstruction techniques, excluding
other techniques from the study [14,23,24]; or they are limited to patients who underwent
breast cancer surgery, excluding risk reduction surgeries [25].
The objective has been to evaluate the satisfaction and quality of life in women who
have undergone mastectomy with breast reconstruction, compare the esthetic results, and
identify risk factors that may influence these results.
2. Materials and Methods
2.1. Study Design
This study is a descriptive cross-sectional study of women who underwent mas-
tectomy surgery with reconstruction and were submitted to a questionnaire of satisfac-
tion and quality of life specific to breast reconstructive surgery (BREAST-Q Version 2.0—
Reconstruction module, validated in Spanish).
2.2. Study Population
Patients undergoing mastectomy with breast reconstruction from 2010 onwards, at
the Hospital Universitario Torrecárdenas and in private clinics in Almería, operated on by
the same surgical team, met the following selection criteria:
• Women with breast cancer with an indication for a mastectomy followed by recon-
struction.
• Women with breast cancer who refuse conservative treatment.
• Women undergoing uni- or bilateral risk reduction surgery followed by reconstruction.
• Who has undergone surgery at least 12 months before the time of inclusion in the
study.
• Who sign informed consent for inclusion in the study.
Exclusion criteria were:
• Women with early metastatic disease (stage IV).
• Women with inflammatory carcinoma.
2.3. Sample Size
Patients who had undergone mastectomy with breast reconstruction since 2010 oper-
ated on at the Hospital Universitario Torrecárdenas and in private clinics in the province
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of Almería by the same surgical team and met the criteria for inclusion in the study
were selected. The type of sampling was by convenience through access to the patients’
medical records.
The sample size was calculated based on a series of estimates considering the latest
data recorded on the number of patients diagnosed with breast cancer and undergoing
mastectomy in the province of Almeria during the year 2020, whose figure was 111 patients.
For a finite population, the Ene 3.0 statistical program (UAB, Barcelona, Spain) was
used to obtain the sample size, assuming an alpha error of 0.05, an expected proportion of
50%, and a precision of 5%, obtaining an estimated sample of 70 patients.
2.4. Data Collection and Sources of Information
After signing the corresponding informed consent, the patients selected during the
period included in the study were invited to participate in the study by filling in the
questionnaires referred to above, with at least one year having elapsed since the surgical
intervention. A series of pre-and post-surgical variables of a demographic nature and relat-
ing to the characteristics of the tumor, surgical intervention, complications and adjuvant
treatments, obtained from the patient’s clinical history, were also collected.
2.5. BREAST-Q© Questionnaire
The questionnaire is a PRO tool designed to evaluate the results of women undergoing
different types of breast surgery. Drs. Pusic, Klassen, and Cano developed it and it is owned
by Memorial Sloan-Kettering Cancer Center and Columbia University (U.S.). Version 1.0 of
the questionnaire was published in 2009 and has been available in Spain since 2016 after
linguistic validation. In 2017, version 2.0 of the questionnaire was published, which is the
one currently used.
The questionnaire contains six modules, of which the first two are related to cosmetic






c. Breast reconstruction expectations;
d. Breast-conserving surgery.
Each module, in turn, is divided into multiple scales that can be used independently,
allowing each researcher to generate a questionnaire tailored to his or her research. In
addition, each module has preoperative and postoperative scales, which can be used
individually or together, allowing changes over time to be assessed.
All modules are based on a conceptual structure comprising six domains, grouped
into the two described below. In addition, due to the importance of body image for breast
surgery patients, numerous questionnaire scales allow the measurement of this concept.
2.5.1. Health-Related Quality of Life
a. Psycho-social well-being: this scale contains items that inquire into the patient’s
body image (e.g., body acceptance, feeling of being attractive) and her confidence in
certain social situations;
b. Sexual well-being: Its items are intended to measure the patient’s sexual well-being
through questions about sensations when she is dressed or naked, her sexual confi-
dence concerning the appearance of her breasts and her sensations during sexual
activity;
c. Physical well-being: This scale differs between the different modules. Depending on
which one we are in, we will see questions relating to physical problems in the chest,
back, abdomen or skin due to the adverse effects of radiotherapy.
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2.5.2. Patient Satisfaction
a. Breast Satisfaction. This scale measures body image through patients’ satisfaction
with their breasts, based on questions about the comfort of the operated or recon-
structed breasts, both clothed and unclothed. It also evaluates symmetry, breast
smoothness, and some items related to implants in the reconstruction module;
b. Satisfaction with the results. It includes items related to the patient’s satisfaction
with the appearance after surgery of the nipple-areola complex, especially regarding
the scars;
c. Satisfaction with the care received. It is a scale that only this questionnaire has and
which makes it possible to evaluate the patients’ satisfaction with several points of
their surgical process: the information received from their surgeon on the proce-
dures and recovery times, satisfaction with the surgeon (professionalism, sensitivity,
communication skills, accessibility), satisfaction with the care received by the rest of
the medical team and satisfaction with other non-medical personnel involved in the
process (for example, administrative personnel).
As mentioned above, it is not necessary to complete all the modules, but they are
completed independently according to the purpose of each study. Brief instructions are
given at the beginning of each scale to allow the patient to understand the items better. In
addition, the questionnaire user’s guide expressly states that its use is permitted both in
printed format and by creating its online version to facilitate its administration to the study
subjects 88.
An overall score is not obtained for the questionnaire; each scale is scored indepen-
dently. All scores fluctuate between 0 and 100, so that a higher score implies greater
satisfaction or better quality of life.
Finally, since the questionnaire is the property of Memorial Sloan-Kettering Cancer
Center and Columbia University, in order to use it for research purposes, a license for its
use must be obtained, free of charge, through their official website (http://qportfolio.org/
breast-q/(Accessed on 4 January 2021)).
2.6. Study Variables
2.6.1. Independent Variables
• Age (at the time of surgery): quantitative variable expressed in years;
• Body mass index: quantitative;
• Tobacco use YES/NO: dichotomous qualitative variable;
• Educational level (Low/Medium/High): ordinal qualitative variable;
• Previous surgery (No/Benign surgery/Conservative surgery for cancer + Radiother-
apy/Augmentation surgery/Reduction-pexy): qualitative variable;
• Reason for the intervention (Cancer/High risk/BRCA/BRCA + cancer);
• Tumor location within the breast: qualitative variable;
• Tumor size (mm): quantitative variable, expressed in millimetres;
• Tumor extension (Single/Multifocal/Multicentric/Extensive): qualitative variable;
• Molecular subtype (Luminal A/Luminal B/Triple positive/Her two neu overexpressed/
Basal-like): qualitative variable;
• Tumor pathologic TNM (Tis/T1/T2/T3): ordinal qualitative variable;
• Nodal pathologic NCT (N0/N1/N2): ordinal qualitative variable;
• Tumor stage (0/I/IIA-B/IIIA-B): ordinal qualitative variable;
• Date of surgery;
• Type of surgery: classic mastectomy/skin-sparing mastectomy type I-II/skin-sparing
mastectomy type IV/skin- and nipple-sparing mastectomy/partial + dorsal mastec-
tomy): qualitative variable;
• Timing of breast reconstruction (Immediate/Different): dichotomous qualitative variable;
• Type of reconstruction (Expansion-prosthesis/Becker-type expander/direct implant/
dorsal-prosthesis/biological mesh): qualitative variable;
• Treatment of the axilla (No/BSGC/axillary lymphadenectomy): qualitative variable.
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• Implant size: quantitative variable expressed in grams;
• Chemotherapy (No/Neoadjuvant/Adjuvant): qualitative variable;
• Radiotherapy (No/Over expander/Over prosthesis/Over Becker/Over flap): qualita-
tive variable;
• Contralateral breast symmetrization (NO/Augmentation/Reduction/Pexia + Im-
plant/Preventive mastectomy): qualitative variable.
2.6.2. Dependent Variables
• Immediate complications (No/Seroma/Wound dehiscence/Skin or flap necrosis/CAP
necrosis/Implant extrusion): qualitative variable;
• General evolution after the first intervention (Favorable/Reoperation): qualitative
dichotomous variable;
• Late complications of breast reconstruction (Satisfactory/Discomfort/Asymmetry/
Contracture III-IV/Discomfort + Asymmetry/Implant rupture/Delayed seroma/Others):
qualitative variable;
• Post-surgical complications of the symmetrized breast (NO/YES): dichotomous quali-
tative variable;
• Number of reoperations: discrete quantitative variable;
• Oncologic outcome (Disease-free/Systemic recurrence/Local recurrence/Exitus): qual-
itative variable;
• Date of completion of the questionnaire;
• Time elapsed between breast reconstruction and completion of the questionnaire in
years: quantitative variable;
• Time elapsed between breast reconstruction and completion of the grouped question-
naire (1–3 years/4–6 years/7–9 years/10 years): qualitative variable;
• Results of the BREAST-Q questionnaire version 2.0 Post-surgical reconstruction module.
2.7. Ethical Implications
The project complies with the ethical principles of human research in the Declaration
of Helsinki and the Biomedical Research Act. Likewise, it complies with the stipulations
of the Organic Law 3/2018, of 5 December, on Personal Data Protection and guarantee of
digital rights, guarding its strict confidentiality and its non-access to unauthorized third
parties, as well as with the European Union Regulation 2016/679. Each patient who wished
to participate was provided with a copy of the patient information sheet and informed
consent. The Hospital Torrecárdenas Ethical Committee approved the study Code number:
47/2021.
2.8. Statistical Analysis
The study variables and questionnaire scores will be collected in a database and
subsequently analyzed with IBM SPSS 26 (IBM Corp. Released 2019.Version 26.0. IBM
Corp, Armonk, NY, USA).
A descriptive analysis of the main variables will be performed. For qualitative vari-
ables, their frequency distribution (number of cases and percentage) will be obtained.
Quantitative variables will be expressed as a minimum, maximum, mean and standard
deviation. Before performing the bivariate analysis, normality tests will be performed for
quantitative variables using the Kolmogorov-Smirnov test. Parametric tests (Pearson’s
correlation, t-Student, and ANOVA) will be used for those following a normal distribution
and non-parametric tests (Spearman’s correlation, Mann Whitney U, and Kruskal-Wallis)
for those not following a normal distribution.
3. Results
3.1. Descriptive Statistics
Seventy participants were included in the study, of which 50 returned the question-
naire correctly completed (71.42%). The most relevant demographic and preoperative
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characteristics of the study sample are described in Tables 1 and 2. The mean age of
the study population was 45.94 (7.85) years, and the mean time elapsed between breast
reconstruction and completion of the questionnaire was 4.52 (3.22) years
Table 1. Demographic characteristics and preoperative conditions (I).
Minimum Maximum Mean Std. Deviation
Age at diagnosis 26 64 45.94 7.85
BMI * 17.72 35.16 24.85 3.58
Tumor Size (mm) 5 75 31.44 17.06
Implant Size (cc or grs) 200 560 370.9 80.71
Number of reoperations 0 5 0.99 1.15
Years from mastectomy to
questionnaire completion 1 10 4.52 3.22
* BMI = Body Mass Index.






Primary education 9 23.1%
Secondary education 13 33.3%




Localization of primary tumor
Upper-outer quadrant 37 56.1%
Upper-Inner quadrant 9 13.6%
Lower-outer quadrant 4 6.1%







Concerning the qualitative variables studied, we found that 24.2% of the patients
studied were smokers; 43.6% had a high level of education, and 25% of them had previously
undergone surgery on the affected breast, either for esthetic reasons or for benign pathology.
In terms of tumor characteristics, the most frequent tumor location was the upper
outer quadrant in 56.1% of cases, and 62.1% of patients were stage II A/B at the time
of surgery.
The most important characteristics of surgery, adjuvant therapy and evolution of
patients of study are described in Table 3. The most frequently performed intervention was
skin-sparing mastectomy type I/II in 44.1% of the patients. Immediate post-mastectomy
reconstruction was carried out in 94.1% of the patients in the same surgical act, the most
frequently used technique being reconstruction with alloplastic tissue, with a two-stage
expander-prosthesis in 30.9% of cases, followed by reconstruction with a Becker-type
expander (25%) and reconstruction with a latissimus dorsi muscle flap (25%). A total of
57.4% of the patients underwent surgery to symmetrize the contralateral breast, either in the
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same surgical procedure or at a second stage. This surgery was a preventive mastectomy
in 16.2% of them.
Table 3. Characteristics of surgery, adjuvant therapy and evolution of patients.
Variable n %
Type of mastectomy
Skin-sparing type I–II 31 45.6%
Skin-sparing type IV 8 11.7%
Nipple skin-sparing 10 14.7%






Becker expander 17 25%
Latissimus dorsi muscle flap 17 25%
Matrix acellular 6 8.8%
Direct prosthesis 7 10.3%
Lymph node management
None 2 2.9%
Sentinel lymph node biopsy 39 57.4%











Evolution after first surgery
Successful 33 48.5%
Reoperation 35 51.5%
In terms of adjuvant treatment, 39.7% of the patients studied received radiotherapy on
the reconstructed breast, while 64.7% of them received chemotherapy (26.5% neo-adjuvant
chemotherapy and 38.2% adjuvant chemotherapy).
We also analyzed the evolution of the patients after the first surgery. A total of
51.5% of them had to undergo at least one second operation, with the maximum number
of reoperations found being five. A total of 19.1% suffered some type of immediate
complication after surgery, the most frequent being skin necrosis in 5.9% of cases. A total of
56.7% of the patients suffered a late complication that forced them to undergo reoperation,
the most frequent complication being Baker’s grade III–IV capsular contracture in 44.8%
of cases.
The mean scores obtained in the scales studied in the BREAST-Q questionnaire are
described in Table 4. The scale with the lowest score is sexual well-being, with a mean of
51.84 (21.13) points; the scales with the highest scores are those evaluating satisfaction with
the care received: satisfaction with the surgeon with a score of 91.86 (18.11), satisfaction
with the surgical team with a mean of 88.58 (20.06), and satisfaction with the hospital with
81.8 (23.63) points.
3.2. Differential and Bivariate Analyzes
3.2.1. Health-Related Quality of Life Scales
Table 5 shows the differences obtained between the main scores obtained in the
health-related quality of life scales and the main variables studied.
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Table 4. Results of the BREAST -Q questionnaire.
Breast-Q Scales Minimum Maximum Mean Std. Deviation
Psychosocial well-being 18 100 64.84 21.35
Sexual well-being 14 100 51.84 21.13
Physical well-being 14 100 62.83 22.11
Satisfaction with surgical results 0 100 55.86 16.84
Satisfaction with information 30 100 67.47 18.56
Satisfaction with the surgeon 0 100 91.86 18.11
Satisfaction with the surgical team 0 100 88.58 20.06
Satisfaction with the hospital 0 100 81.8 23.63
Table 5. Differences between health-related quality of life scales mean scores and qualitative variables studied.









0.49 *No 66.53 (20.86) 53.43 (22.05) 63.23 (21.11)
Education level





0.91 **Secondary education 55.83 (22.30) 45.75 (24.96) 58.67 (24.42)
University degree 62.97 (22.06) 58.62 (25.21) 62.25 (19.38)




0.07 *No 69.16 (20.59) 56.03 (19.50) 66.26 (21.48)







Upper-inner 65.17 (31.08) 50.17 (27.48) 55 (28.69)
Lower-outer 57.67 (5.68) 49.33 (5.77) 48.33 (10.40)
Lower-inner 54.60 (20.18) 37.20 (17.62) 39.60 (14.58)








I 63.00 (27.88) 50.78 (31.21) 59.78 (20.89)
IIA-B 64.86 (17.99) 49.32 (17.12) 60.63 (22.53)
IIIA-B 62.89 (24.45) 56.22 (22.90) 62.26 (22.40)
Type of mastectomy






Skin-sparing type IV 78.17 (13.36) 52.50 (10.34) 66.00 (14.47)
Nipple skin-sparing 66.00 (22.49) 56.67 (25.73) 71.22 (19.65)
Radical mastectomy 62.88 (21.85) 52.94 (21.27) 64.20 (27.02)












Becker expander 76.23 (15.81) 62.23 (18.59) 67.67 (19.11)
Latissimus dorsi muscle flap 57.60 (24.11) 48.70 (24.86) 67.67 (26.66)
Matrix acellular 55.40 (18.55) 50 (26.62) 65.60 (21.27)







0.25 **Sentinel lymph node biopsy 59.38 (21.88) 47.85 (22.50) 58.00 (20.31)
Axillary lymph
node dissection 70.00 (20.22) 54.86 (18.33) 67.33 (24.16)











0.80 **Neo-adjuvant 65.69 (18.32) 54.23 (17.65) 59.17 (22.98)
Adjuvant 66.11 (22.44) 50.42 (21.17) 64.61(24.93)º











0.89 *Reoperation 63.14 (20.97) 50.43 (21.29) 62.44 (24.73)
* p-value obtained by t-Student; ** p-value obtained by ANOVA.
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When comparing the psycho-social well-being scale score according to other factors
related to the patients and their intervention, we found a statistically significant association
(p = 0.01) between the score on this scale and the history of previous surgery on the affected
breast. The mean score among patients with some previous surgery was 52.54 (19.16)
points, compared to 69.16 (20.59) points in those with no previous history. This association
was also found when comparing the mean score of the sexual well-being scale with this
personal history of the patient, finding a mean score of 56.03 (19.50) points among patients
with no history of surgery, compared to 39.92 (21.75) points among those with previous
surgery (p = 0.01).
When comparing the mean scores of physical well-being according to the location of
the primary tumor, we found a mean score of 70.78 (19.40) when the tumor was located in
the superior external quadrant of the breast, compared to 39.60 (14.58) when it was located
in the inner-internal quadrant, this difference being statistically significant (p = 0.01).
We found no statistically significant association between the mean score on the three
quality of life scales and the timing or type of breast reconstruction performed.
Table 6 describes the results obtained by correlating the score on the health-related
quality of life scales with the different quantitative variables studied. We found no statisti-
cally significant association between the mean score in psycho-social well-being with any
of them.





Age −0.15 0.27 *
BMI −0.26 0.06 *
Tumor size −0.22 0.13 **
Implant size −0.14 0.32 **






Age −0.35 0.01 **
BMI −0.16 0.26 **
Tumor size −0.03 0.79 **
Implant size −0.20 0.15 **






Age −0.25 0.08 *
BMI −0.22 0.13 *
Tumor size −0.01 0.91 **
Implant size −0.01 0.90 **





* p-value obtained by Pearson’s correlation coefficient; ** p-value obtained by Spearman’s correlation coefficient.
When comparing the mean score of the sexual well-being scale with the quantitative
variables, we found an inverse correlation between the score on this scale and the patient’s
age (r = −0.35; p = 0.01) without finding an association with the rest of the variables studied.
Finally, we found no statistically significant relationship between the mean score of
physical well-being with the quantitative variables studied (Table 5).
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3.2.2. Patient Satisfaction
Table 7 shows the differences between the mean scores in patient satisfaction scales
and the qualitative variables studied, and Table 8 shows the results after correlating the
mean score on both scales with the quantitative variables of the study.
Table 7. Differences between satisfaction with results scales mean scores and qualitative variables studied.
Variables Satisfaction withBreasts p
Satisfaction with the
Reconstruction of the NAC p
Smoking No 54.37 (17.57) 0.83 *
2.64 (1.21)
0.10 ***Yes 55.47 (15.29) 1.75 (1.16)
Education level
Primary education 55.89 (11.46)
0.35 **
1.71 (1.50)
0.44 ****Secondary education 50.50 (22.28) 2.63 (1.18)













Upper-inner 58.33 (11.69) 2.80 (1.30)
Lower-outer 53.00 (5.56) 3.00 (0.00)
Lower-inner 51.80 (12.29) 1.00 (0.00)






I 58.67 (25.66) 2.00 (1.15)
IIA-B 53.96 (15.92) 2.19 (1.17)
IIIA-B 57.56 (8.08) 2.00 (1.41)
Type of
mastectomy




Skin-sparing type IV 62.00 (14.85) 2.80 (0.83)
Nipple skin-sparing 61.00 (20.03) 3.22 (0.97)














Becker expander 58.67 (17.91) 2.25 (1.16)
Latissimus dorsi muscle flap 58.30 (8.73) 2.40 (1.51)
Matrix acellular 58.60 (13.66) 2.80 (1.64)






0.44 ****Sentinel lymph node biopsy 57.59 (16.26) 2.44 (1.26)











0.99 ****Neo-adjuvant 55.08 (21.01) 2.20 (1.30)











0.39 ***Reoperation 56.29 (16.67) 2.30 (1.21)
* p-value obtained by t-Student; ** p-value obtained by ANOVA; *** p-value obtained by Mann Whitney U; **** p- value obtained by
Kruskal-Wallis.
No statistically significant association was found between mean score in satisfaction
with breast scale with any of the variables studied, both quantitative and the rest of
qualitative variables.
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NAC reconstruction was performed in 33 of the patients surveyed. Of these, 45.5%
reported being dissatisfied with the results. We found a statistically significant inverse
relationship between the mean score on satisfaction with NAC reconstruction scale and the
years since surgery, with a correlation coefficient of −0.40 (p = 0.02).
Table 8. Correlation between the score on the satisfaction with results scales and patient’s characteristics.
Correlation p
Satisfaction with the breasts
Age 0.007 0.96 *
BMI −0.12 0.40 *
Tumor size −0.09 0.51 **
Implant size −0.16 0.24 **
Reoperations 0.07 0.61 **
Years between surgery and the questionnaire −0.07 0.59 **
Satisfaction with the reconstruction of the NAC
Age −0.22 0.20 *
BMI −0.16 0.35 *
Tumor size −0.20 0.27 *
Implant size −0.07 0.66 *
Reoperations −0.22 0.20 *
Years between surgery and the questionnaire −0.40 0.02 *
* p-value obtained by Pearson’s correlation coefficient; ** p-value obtained by Spearman’s correlation coefficient. NAC = Nipple Areola Complex.
Evaluating the rest of the qualitative variables, we found no statistically significant
differences between the mean scores on the scale. Although there was a difference in the
mean score according to the type of mastectomy: skin-sparing mastectomy type I–II had a
mean of 1.91 (1.13), compared to the skin-nipple-sparing mastectomy with a mean of 3.22
(0.97) and skin-sparing mastectomy type IV whose mean was 2.80 (0.83). However, these
differences did not reach statistical significance (p = 0.07).
The rest of the scales studied (satisfaction with the information received, satisfaction
with the surgeon, satisfaction with the medical team and satisfaction with the hospital) are
included in the care received. Table 9 shows the differences obtained between the mean
scores in those scales and most important variables studied.
Concerning the satisfaction scale with the information received, we found differences
in the mean score depending on when the breast reconstruction was performed. In those
cases where immediate reconstruction was performed, the mean score was higher with a
mean of 68.80 (18.69), compared to those with delayed reconstruction, whose mean was
52.50 (8.02), this difference being statistically significant (p = 0.04). No relationship was
found between the mean score of this scale and the rest of the variables studied.
The mean score on the surgeon satisfaction scale was associated with the patient’s
tumor stage at diagnosis. Women with stage II A-B had a mean score of 95.07 (9.98) points
compared to those with stage 0, whose mean score was 43 (60.81) points; this difference was
statistically significant (p = 0.04). The score on this scale was also associated with the type
of breast reconstruction performed. Patients who underwent direct implant reconstruction
had a mean score on this scale of 100 points compared to 85.90 (17.34) points in those who
underwent latissimus dorsi flap reconstruction. This difference is statistically significant
(p = 0.04).
Finally, the mean scores on the scales of satisfaction with the surgical team and
satisfaction with the hospital were associated with the patient’s level of education. Patients
with a high level of education scored higher on both scales than those with a low level
of education. In the case of the satisfaction with the surgical team scale, the mean score
in the highly educated patients was 96.44 (9.93) points compared to 72.33 (32.91) points
in the low educated group (p = 0.02). On the hospital satisfaction scale, the mean score
was 91.75 (14.16) points in the high-level group versus 60.89 (27.32) points in the low-level
group (p = 0.003).
Int. J. Environ. Res. Public Health 2021, 18, 9707 13 of 18













p Satisfactionwith Hospital p
Education level








education 62.08 (14.91) 92.25 (11.34) 88.00 (17.90) 87.58 (19.32)




















I 72.00 (19.74) 95.44 (13.67) 94.67 (12.97) 89.78 (16.28)
IIA-B 65.64 (18.98) 95.07 (9.98) 90.11 (15.88) 80.59 (22.84)











IV 67.33 (18.00) 98.67 (3.22) 92.00 (15.60) 88.67 (14.77)
Nipple skin-sparing 80.11 (20.78) 95.44 (13.66) 93.67 (12.85) 88.89 (14.89)
Radical





















Becker expander 66.00 (17.40) 90.92 (15.13) 87.69 (16.56) 80.92 (26.49)
Latissimus dorsi
muscle flap 62.30 (18.80) 85.90 (17.34) 89.30 (16.37) 86.00 (19.15)
Matrix acellular 78.20 (22.16) 96.40 (8.05) 96.40 (4.93) 84.60 (16.05)
Direct prosthesis 64.86 (25.91) 100.00 (0.00) 94.43 (14.74) 92.14 (14.49)















0.72 *Reoperation 63.04 (14.88) 92.57 (13.90) 89.11 (16.67) 82.63 (18.97)
* p-value obtained by Mann Whitney U; ** p-value obtained by Kruskal-Wallis.
4. Discussion
The development of the BREAST-Q questionnaire in 2009 laid the groundwork for
assessing the satisfaction and quality of life of women undergoing breast surgery with a
validated tool that allows the measurement of patients’ perceptions. Since its publication,
it has become the gold-standard PRO instrument used in breast surgery.
In addition to its excellent metric properties, since it is a self-administered ques-
tionnaire, which can even be filled out online, it facilitates its completion by the patient
independently, which verifies her answers. In our study, of the 70 participants included,
71.42% returned the questionnaire correctly completed, this response rate being in line
with that found in other studies [26].
4.1. Health-Related Quality of Life
In the three scales related to health-related quality of life (HRQOL): psycho-social
well-being, sexual well-being and physical well-being, we found no association with the
patient’s body mass index, while other similar studies have found that. These results are
surprising since the relationship between BMI and HRQOL has already been extensively
studied, finding that the effect of BMI on HRQOL is independent of disease severity [27].
In contrast, other studies have shown that obesity is associated with worse outcomes and
poorer survival in women with breast cancer [28].
Regarding sexual well-being, it is the scale with the worst mean score of the entire
questionnaire, which corresponds to that found in the literature when compared with other
similar studies [23,29,30]. The negative relationship between age and sexual well-being
is widely described in other studies, so it does not seem to be an association specific to
mastectomy patients [31]. Multiple studies have evaluated sexual well-being in patients
after breast cancer, some of which report that sexual dysfunction can affect up to 90%
of women treated for breast cancer [32]. These problems are generally associated with
the disturbance suffered in the patient’s body image after surgery [33], constituting an
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essential long-term side effect of the treatments used [34]. In particular, sexual dysfunction
in body image worsens in women treated with mastectomy compared to conservative
treatment [35]. Furthermore, an impact on sexuality has also been demonstrated in women
who undergo prophylactic mastectomy, so this should be a side effect to consider and
inform patients who request this type of risk-reducing surgery [36].
Our study found no statistically significant differences between the patients’ quality
of life in the three domains studied (psycho-social, sexual, and physical well-being) and
the time and type of breast reconstruction performed. These results differ from what
has been found so far in the literature. A systematic review published in 2018 by Liu
et al. included 54 studies evaluating the quality of life and satisfaction of patients who
underwent breast oncoplastic surgery using the BREAST-Q questionnaire. The authors
found higher scores in the three HRQOL domains, comparing immediate reconstruction
with delayed reconstruction and autologous tissue versus reconstruction with implants [37].
In our study, the lack of significance is most likely due to the small sample size, in which
92.2% of the patients underwent immediate reconstruction.
4.2. Satisfaction with the Results
This domain of the BREAST-Q questionnaire includes the scales of satisfaction with
the breasts, the implants, the reconstruction of the nipple-areola complex (NAC), and the
care received.
The study did not find a statistically significant relationship with the factors studied
regarding satisfaction with the breasts. Differences were observed between the mean
scores on the scale according to the type of mastectomy. However, they almost reached
significance (p = 0.07), finding that skin-sparing mastectomy type IV and skin- and nipple-
sparing mastectomy obtained slightly higher scores than classic mastectomy and skin-
sparing mastectomy type I-II. Compared with the existing literature in this regard, Nelson
et al. in a study published in 2019 reported lower breast satisfaction in classic mastectomy
compared to the rest of the techniques. In addition, in that study, lower breast satisfaction
was associated with other factors such as having received postoperative chemotherapy or
radiotherapy and non-symmetrization of the healthy breast [24]. By increasing the sample
size of our study, we expect to find more relevant results related to this scale.
This study did not find a relationship between satisfaction with the results studied
(breast, implants, and NAC reconstruction) and postoperative radiotherapy. Studies on this
subject show an increase in morbidity in all forms of breast reconstruction in the context
of post-surgical radiotherapy [38]. The meta-analysis reported a complication rate of four
times higher than breast reconstructions that had not undergone radiotherapy afterwards.
The most frequent complications were capsular contracture, pain, and distortion of the
implant [38,39].
Nipple-areola complex (NAC) reconstruction was performed in 33 of the patients
surveyed. Of these, 45.5% reported being dissatisfied with the results, which shows that,
despite the potential physical and psychological impact on the patient performing this last
step of breast reconstruction, the results obtained reduce patient satisfaction. We found a
statistically significant inverse relationship between the mean score on this scale and the
years since surgery, with a correlation coefficient of −0.40 (p = 0.02). On the other hand, we
did not find a statistically significant association between the type of surgical technique
used to perform the mastectomy and satisfaction with the reconstruction of the NAC.
This result differed from the findings of other studies showing that nipple-skin-sparing
mastectomy is a more accepted technique because it preserves body integrity and reduces
the feeling of mutilation. In addition, preserving the NAC from the beginning does not
require specific reconstruction of the NAC, so the esthetic results are better [40].
4.3. Satisfaction with the Results
The subscales included in the satisfaction with the care received are the most neglected
of the BREAST-Q questionnaire. At the same time, they are a strong point of this question-
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naire, as no others take these aspects into account [41]. The studies have shown that the
patient’s subjective evaluation of the results after breast reconstruction considers both the
cosmetic results and the trust placed in the medical team and the feeling of being cared for
by them [42]. The surgeon–patient relationship has a significant influence on the results
perceived by the patients [43].
High scores were obtained on the scales relating to satisfaction with the surgeon,
the surgical team, and the hospital. Although in the scale related to satisfaction with
the information received, a lower mean score of 67.47 (18.56) points was obtained. This
distribution of scores on these scales agrees with what has been found in the literature to
date [13,30].
As for the factors that could influence satisfaction with the care received, the most
striking association was found between the patient’s level of education and satisfaction
with the surgical team and the hospital; the lower the level of education, the lower the
satisfaction with the two scales.
Finally, an essential point of our study was to analyze the evolution of the patients
after surgery, finding that 51.5% of them had to undergo at least one-second operation.
A Canadian study published by Roberts et al. reported a mean reoperation rate after the
first reconstruction surgery of two operations over a 5-year follow-up period [44]. In our
study, the mean number of reoperations per patient was 1.00 (1.15) with a maximum of up
to 5 operations. Another study published by Boughey et al. showed a strong association
between the rate of reoperations and lower overall patient satisfaction [45]. In our study, we
found no association between the number of reoperations and other satisfaction scales of
the questionnaire. However, this may be due to the small sample size, so we will continue
this line of research in future studies.
5. Strengths and Weakness of the Study
The main limitation of the study is the reduced sample size of 70 patients, although
the calculated sample size was met, as reflected in the methodology, for the population
studied and other similar studies have even smaller sample sizes.
The type of sampling by which the study sample was chosen is a convenience sample,
a non-probabilistic and non-random sample, as the patients were chosen because of the
ease of access to their medical records, which means that it may not be a representative
sample of the population. In addition, by selecting patients operated on by the same
surgical team there may be a selection bias, although this is also a strength of the study, as
having been operated by the same team the surgical techniques are more comparable, and
so are the results.
Patients were followed up for up to 10 years, which is one of the strengths of the
study. However, with such a long study period, it is possible that some patients may not
be contacted, or that some may have died, so that data will be lost.
Finally, another potential limitation of our study is that we do not know the baseline
status of the patients in terms of their well-being and satisfaction. Since the BREAST-Q©
questionnaire also has preoperative scales, it would be interesting for future studies to
analyze the state of the patients before surgery in order to better assess their changes.
6. Conclusions
The BREAST-Q© questionnaire was confirmed as a suitable tool that is easy to admin-
ister and complete to assess the quality of life and satisfaction of patients who underwent
mastectomy and breast reconstruction.
The sexual well-being scale is the worst scored of all the questionnaires, which con-
firms the negative impact that mastectomies have on body image and sexuality, even those
performed prophylactically. Reconstruction of the nipple-areola complex often leads to
decreased patient satisfaction with the esthetic results, contrary to the initial objective of
reconstructive surgery, which is to improve the sensation of mutilation and its impact on
body image. More than half of the patients in the study had to undergo at least a second
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surgery after reconstruction, so it is essential to consider this rate because of its possible
influence on the quality of life and patient satisfaction.
Finally, evaluating satisfaction with medical care is as critical as evaluating cosmetic
results since the surgeon-patient relationship can affect overall satisfaction with the process.
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